Exploring the potential of artemisinin in autoimmune care! 🌿 Beyond its antimalarial roots, this compound and its derivatives show promise in modulating immune responses for autoimmune and inflammatory diseases.
Artemisinin derivatives suppress harmful immune responses through key pathways like NF-κB and PI3K/AKT/mTOR, curbing T-cell activation and inflammatory cytokines. Ongoing clinical trials aim to translate these findings into therapies for conditions such as rheumatic and skeletal disorders.
To view the online publication, click here: https://bit.ly/4hqJvZG#Immunology#Autoimmune#IntegrativeHealth
Going to leave this here for the nerds 🤓
Great review of the immune-related biochemistry in autoimmune disease - with interesting implications in lupus, Sjögren’s syndrome, RA and others.
"These downstream targets regulate various immune cell functions, apoptosis, proliferation, signal transduction, and antioxidant responses, ultimately intervening in systemic autoimmune diseases and autoimmune responses in organs such as the kidneys, nervous system, skin, liver, and biliary system by modulating immune dysregulation and inflammatory responses. Ongoing multicenter randomized clinical trials are investigating the effects of these compounds on rheumatic, inflammatory, and autoimmune diseases, with the aim of translating promising preclinical data into clinical applications"
#autoimmunedisease#wholepersoncare#cam#pharmacist#functionalmedicine
Exploring the potential of artemisinin in autoimmune care! 🌿 Beyond its antimalarial roots, this compound and its derivatives show promise in modulating immune responses for autoimmune and inflammatory diseases.
Artemisinin derivatives suppress harmful immune responses through key pathways like NF-κB and PI3K/AKT/mTOR, curbing T-cell activation and inflammatory cytokines. Ongoing clinical trials aim to translate these findings into therapies for conditions such as rheumatic and skeletal disorders.
To view the online publication, click here: https://bit.ly/4hqJvZG#Immunology#Autoimmune#IntegrativeHealth
Exciting new research published in the eLife sheds light on the critical role of IL-27p28 in regulating CD4+ T cell function. Zhang and colleagues demonstrated how IL-27p28 deficiency leads to enhanced IFN-γ production in T cells through epigenetic modifications, upregulation of STAT1 activity, and a bias towards the Th1 lineage. Their findings provide valuable insights into immune regulation and autoimmune disease pathogenesis. #ImmunologyResearch#CD4TCells#TCells
Discover how the Cytokine 4-Plex A Assay is uncovering critical insights into early biological and pathological processes, advancing our understanding of inflammation and immune function. Explore the applications of C4PA today!
Discover how the Cytokine 4-Plex A Assay is uncovering critical insights into early biological and pathological processes, advancing our understanding of inflammation and immune function. Explore the applications of C4PA today!
#ACROHighlights [Featured Product]
🔬 Discover the Power of TL1A and DR3 Proteins!
Unlock the potential of the TL1A/DR3 pathway in regulating immune responses and inflammation. TL1A, a vital stimulator that enhances mucosal tissue immunity, holds promise in treating autoimmune diseases. By blocking the TL1A/DR3 pathway, you can reduce the impact of inflammatory conditions like rheumatoid arthritis, psoriasis, and more.
Join the growing wave of research on TL1A and DR3! Our extensive catalog offers TL1A/DR3 proteins and a TL1A stable cell line, designed to accelerate your research. Find the perfect fit for your needs with various species, tags, and labels.
👉 Explore our TL1A/DR3 offerings: https://smpl.is/91mrk#Biotech#Immunology#AutoimmuneDiseases#ResearchAccelerator
Discover how the Cytokine 4-Plex A Assay is uncovering critical insights into early biological and pathological processes, advancing our understanding of inflammation and immune function. Explore the applications of C4PA today!
Discover how the Cytokine 4-Plex A Assay is uncovering critical insights into early biological and pathological processes, advancing our understanding of inflammation and immune function. Explore the applications of C4PA today!
MSc, PhD, Senior FAS at Quanterix accelerating the early diagnosis of neurodegenerative diseases: Alzheimer, Multiple Sclerosis, through ultrasensitive biomarker detection in liquid biopsies
Discover how the Cytokine 4-Plex A Assay is uncovering critical insights into early biological and pathological processes, advancing our understanding of inflammation and immune function. Explore the applications of C4PA today!
Discover how the Cytokine 4-Plex A Assay is uncovering critical insights into early biological and pathological processes, advancing our understanding of inflammation and immune function. Explore the applications of C4PA today!
Clinical Biochemist | Dual Master's in Digital Health and Public Health Management | COVID-19 Expert | Leader in Clinical Diagnostics | Published Scientist.
🔬🩸 Exploring immune dysregulation in long COVID, Ceglarek and Boyman uncover key pathways like complement activation and myeloid inflammation. Through plasma protein profiling, distinct immune profiles emerge, underscoring the heterogeneous nature of this lingering condition. #LongCOVID#ImmuneDysregulation#COVIDResearch
